BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin WR, Liu KH, Ling TC, Wang MC, Lin WH. Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease. World J Diabetes 2023; 14(4): 352-363 [PMID: 37122432 DOI: 10.4239/wjd.v14.i4.352]
URL: https://www.wjgnet.com/1948-9358/full/v14/i4/352.htm
Number Citing Articles
1
Sphelele C. Sosibo, Hendrik G. Kruger, Wonder P. Nxumalo, Zimbili Zondi. Evaluation of Taraxacum officinale phytoconstituents as potential JNK1 inhibitors: Perspectives from ADMET, molecular docking, molecular dynamics, and density functional theoryChemical Physics Impact 2024; 9: 100757 doi: 10.1016/j.chphi.2024.100757
2
Muhammad Kashif, Sumaira Naz, Muhammad Zahoor, Syed Wadood Ali Shah, Jalal Uddin, Muhammad Esa, Haroon ur Rashid, Riaz Ullah, Amal Alotaibi. Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approachesOpen Chemistry 2024; 22(1) doi: 10.1515/chem-2024-0083
3
Fatma Cebeci, Tayyibe Erten. Trachystemon orientalis (L.) G. Don bitkisinin antioksidan aktivite, toplam fenolik madde içeriği ve -glukozidaz enzimi inhibisyon potansiyelinin araştırılmasıGıda ve Yem Bilimi Teknolojisi Dergisi 2024; 0(32): 27 doi: 10.56833/gidaveyem.1488382
4
Yu Wu, Chengsen Liu, Jiandong Cao. Association between triglyceride-glucose index and its composite obesity indexes and cardio-renal disease: analysis of the NHANES 2013-2018 cycleFrontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1505808
5
Lijun Jiang, Liangliang Xu, Wen Sun, Keyu Bian, Yuan Wang. Association between the coexistence of chronic kidney disease and sarcopenia with cardiovascular disease and mortalityAging Clinical and Experimental Research 2025; 37(1) doi: 10.1007/s40520-025-03003-w